课题基金 / 基金详情

项目摘要

项目成果

Randy A. Hall的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):孤儿G蛋白偶联受体GPR 56在神经干细胞(NSC)中高度表达,GPR 56的突变导致人类大脑发育障碍。GPR 56在NSC功能中发挥的关键作用使其成为可能能够高度选择性调节NSC的治疗剂的有吸引力的靶标。然而,目前对GPR 56的基本性质知之甚少。通过治疗剂特异性靶向GPR 56将需要更全面地了解控制受体活化、调节和定位的分子机制。因此,我们将研究GPR 56的激活机制,特别是研究N-末端(NT)脱落是否参与受体激活的问题。我们还将研究控制GPR 56-NT脱落的因素,以及受体活化是否会受到NT结合肽的影响。此外,我们将评估GPR 56活性的调节,通过在前期工作中已经确定的受体的细胞质结合伴侣,包括β-抑制蛋白和PDZ支架。最后,我们将研究控制GPR 56在神经干细胞和其他细胞类型中定位的因素,特别强调确定受体靶向纤毛的重要性。除了提供有关GPR 56基本特性的见解外,这些研究还将为靶向GPR 56作为选择性调节NSC功能的手段治疗各种神经发育和神经退行性疾病奠定基础。
英文摘要
DESCRIPTION (provided by applicant): The orphan G protein-coupled receptor GPR56 is highly-expressed in neural stem cells (NSCs), and mutations in GPR56 cause disordered brain development in humans. The key role that GPR56 plays in NSC function makes it an attractive target for therapeutics that might be capable of highly-selective NSC modulation. However, little is currently known about the fundamental properties of GPR56. The specific targeting of GPR56 by therapeutics will require a more comprehensive understanding of the molecular mechanisms controlling receptor activation, regulation and localization. We will therefore study the mechanism of activation for GPR56, examining in particular the issue of whether shedding of the N-terminus (NT) is involved in receptor activation. We will also study the factors controlling GPR56-NT shedding, as well as whether receptor activation can be influenced by NT-binding peptides. Furthermore, we will assess the regulation of GPR56 activity by cytoplasmic binding partners of the receptor that have been identified in preliminary work, including beta-arrestins and PDZ scaffolds. Finally, we will study the factors controlling GPR56 localization in NSCs and other cell types, with a particular emphasis on determining the importance of receptor targeting to cilia. In addition to providing insights about the fundamental properties of GPR56, these studies will lay the groundwork for targeting GPR56 as a means of selectively modulating NSC function in the treatment of various neurodevelopmental and neurodegenerative diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Disease-Associated Mutations and Ligand Activation of the Adhesion G Protein-Coupled Receptor ADGRB2
  • 批准号:
    10811019
  • 项目类别:
  • 资助金额:
    $43.04万
  • 财政年份:
    2023
  • 负责人:
    Randy A. Hall
  • 依托单位:
Graduate Training in the Pharmacological Sciences
  • 批准号:
    10628838
  • 项目类别:
  • 资助金额:
    $42.44万
  • 财政年份:
    2023
  • 负责人:
    Randy A. Hall
  • 依托单位:
Control of Seizure and Migraine Susceptibility by GPR37L1
  • 批准号:
    10449353
  • 项目类别:
  • 资助金额:
    $48.78万
  • 财政年份:
    2021
  • 负责人:
    Randy A. Hall
  • 依托单位:
Control of Seizure and Migraine Susceptibility by GPR37L1
  • 批准号:
    10279634
  • 项目类别:
  • 资助金额:
    $50.17万
  • 财政年份:
    2021
  • 负责人:
    Randy A. Hall
  • 依托单位:
海外基金